TABLE 1.
Cycle threshold values for LDT and cobas SARS-CoV-2 assays for nasopharyngeal samples stored in four mediaa
Medium | Storage temp (°C) | LDT CT value |
cobas SARS-CoV-2 CT value |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day 0 |
Day 1 |
Day 3 |
Day 7 |
Day 0 |
Day 1 |
Day 3 |
Day 7 |
||||||||||
NUC | ORF | NUC | ORF | NUC | ORF | NUC | ORF | ORF1a | E | ORF1a | E | ORF1a | E | ORF1a | E | ||
M4 | 2−8 | 29.3 | 28.3 | 28.8 | 28.1 | 28.6 | 28.0 | 28.8 | 28.1 | 26.24 | 27.00 | 26.43 | 27.20 | 26.65 | 27.29 | 26.85 | 27.50 |
29.6 | 28.6 | 29.0 | 28.2 | 28.9 | 28.2 | 29.6 | 28.7 | 25.92 | 26.84 | 26.37 | 27.31 | 26.66 | 27.47 | 27.01 | 27.80 | ||
29.3 | 28.3 | 28.6 | 27.8 | 28.2 | 27.2 | 29.0 | 28.2 | 25.99 | 26.81 | 26.23 | 26.9 | 26.54 | 27.16 | 26.83 | 27.47 | ||
−20 | 29.2 | 28.2 | 29.0 | 28.1 | 28.9 | 28.2 | 29.0 | 28.4 | 26.92 | 27.62 | 26.65 | 27.37 | 26.79 | 27.43 | 26.99 | 27.93 | |
28.8 | 27.5 | 29.2 | 28.4 | 27.7 | 27.7 | 29.2 | 28.3 | 26.16 | 27.05 | 26.58 | 27.24 | 26.87 | 27.45 | 26.78 | 27.44 | ||
30.2 | 28.8 | 30.7 | 29.0 | 29.2 | 29.2 | 29.8 | 28.9 | 25.72 | 26.58 | 26.70 | 27.43 | 26.71 | 27.19 | 26.96 | 27.65 | ||
MEM | 2−8 | 29.3 | 28.5 | 29.0 | 28.5 | 28.8 | 28.4 | 29.3 | 28.9 | 26.55 | 27.50 | 26.81 | 27.73 | 26.92 | 27.78 | 26.92 | 28.01 |
28.9 | 28.1 | 28.6 | 28.2 | 28.4 | 28.1 | 28.6 | 27.9 | 26.00 | 26.83 | 26.89 | 27.76 | 27.22 | 28.02 | 27.27 | 28.04 | ||
28.8 | 28.2 | 28.6 | 28.4 | 28.4 | 28.2 | 28.4 | 27.9 | 26.44 | 27.33 | 26.93 | 27.88 | 26.70 | 27.58 | 27.25 | 28.13 | ||
−20 | 30.1 | 28.7 | 29.8 | 28.6 | 29.6 | 28.6 | 29.7 | 28.7 | 26.49 | 27.33 | 26.70 | 27.76 | 27.29 | 28.15 | 27.53 | 28.31 | |
29.7 | 28.0 | 29.2 | 28.4 | 27.8 | 26.5 | 29.4 | 28.6 | 26.54 | 27.59 | 26.99 | 27.99 | 27.35 | 28.21 | 27.58 | 28.50 | ||
28.6 | 27.7 | 28.5 | 28.2 | 28.6 | 28.6 | 29.6 | 29.0 | 26.79 | 27.63 | 27.09 | 27.99 | 27.34 | 28.10 | 27.53 | 28.47 | ||
PBS | 2−8 | 30.1 | 28.7 | 29.0 | 27.8 | 29.7 | 28.7 | 29.7 | 28.7 | 26.77 | 27.28 | 26.73 | 27.62 | 26.88 | 27.95 | 27.17 | 28.14 |
28.0 | 26.9 | 26.2 | 25.5 | 26.8 | 26.0 | 26.8 | 25.9 | 26.42 | 27.24 | 26.79 | 27.53 | 26.80 | 27.57 | 27.22 | 27.99 | ||
29.1 | 28.0 | 28.6 | 28.1 | 28.8 | 28.0 | 29.4 | 28.6 | 26.28 | 27.01 | 26.83 | 27.70 | 26.84 | 27.56 | 26.88 | 27.68 | ||
−20 | 29.7 | 28.7 | 28.7 | 28.0 | 29.1 | 28.2 | 30.1 | 29.3 | 26.15 | 26.88 | 26.65 | 27.49 | 26.95 | 27.73 | 26.86 | 27.93 | |
29.6 | 28.2 | 29.6 | 28.6 | 29.5 | 28.3 | 29.6 | 28.7 | 26.41 | 27.36 | 26.34 | 27.26 | 26.33 | 27.37 | 26.75 | 27.69 | ||
29.8 | 28.5 | 29.0 | 28.0 | 29.3 | 28.8 | 29.8 | 29.1 | 26.52 | 27.40 | 26.85 | 27.80 | 26.60 | 27.46 | 27.06 | 27.99 | ||
Saline | 2−8 | 29.8 | 28.9 | 29.3 | 28.6 | 29.0 | 28.2 | 29.1 | 28.3 | 26.77 | 27.65 | 26.98 | 27.91 | 26.92 | 27.80 | 27.31 | 28.30 |
30.0 | 28.9 | 29.5 | 28.7 | 28.6 | 27.5 | 29.8 | 29.2 | 26.48 | 27.47 | 27.06 | 28.00 | 27.14 | 28.10 | 27.41 | 28.41 | ||
29.7 | 28.7 | 29.3 | 28.9 | 29.7 | 28.9 | 29.9 | 29.1 | 25.99 | 27.07 | 27.06 | 28.03 | 27.28 | 28.30 | 27.42 | 28.47 | ||
−20 | 30.2 | 28.9 | 29.8 | 28.8 | 29.7 | 28.7 | 29.6 | 28.9 | 26.64 | 27.62 | 27.02 | 27.93 | 27.21 | 28.10 | 27.29 | 28.17 | |
29.0 | 27.9 | 29.2 | 28.6 | 30.1 | 29.1 | 29.5 | 28.8 | 26.26 | 27.21 | 26.88 | 27.86 | 27.28 | 28.29 | 27.14 | 28.07 | ||
30.1 | 28.9 | 29.6 | 28.7 | 30.8 | 29.1 | 29.8 | 29.0 | 26.33 | 27.33 | 26.76 | 27.88 | 26.80 | 27.92 | 27.23 | 28.21 |
The nasopharyngeal samples were stored in M4-RT VTM, MEM, PBS, or saline. Twelve samples were created for each medium, allowing for testing of 3 unique samples per assay at both storage conditions. Abbreviations: M4, M4-RT VTM; LDT, laboratory-developed test; NUC, nucleocapsid target; ORF, open reading frame target; E, envelope target; CT, cycle threshold; MEM, minimum essential medium; PBS, phosphate-buffered saline without calcium and magnesium.